203 related articles for article (PubMed ID: 22594864)
1. Abnormal uterine bleeding during the reproductive years.
Davidson BR; Dipiero CM; Govoni KD; Littleton SS; Neal JL
J Midwifery Womens Health; 2012; 57(3):248-54. PubMed ID: 22594864
[TBL] [Abstract][Full Text] [Related]
2. Abnormal uterine bleeding: avoid the rush to hysterectomy.
Hill DA
J Fam Pract; 2009 Mar; 58(3):136-42. PubMed ID: 19284939
[No Abstract] [Full Text] [Related]
3. The medical management of abnormal uterine bleeding in reproductive-aged women.
Bradley LD; Gueye NA
Am J Obstet Gynecol; 2016 Jan; 214(1):31-44. PubMed ID: 26254516
[TBL] [Abstract][Full Text] [Related]
4. Use of the levonorgestrel-IUD in the treatment of menorrhagia: improving patient outcomes while reducing the need for surgical management.
Kaunitz AM; Stern L; Doyle J; Etschmaie MR
Manag Care Interface; 2007 Mar; 20(3):47-50. PubMed ID: 17458481
[TBL] [Abstract][Full Text] [Related]
5. Polypectomy in premenopausal women with abnormal uterine bleeding: effectiveness of hysteroscopic removal.
Henriquez DD; van Dongen H; Wolterbeek R; Jansen FW
J Minim Invasive Gynecol; 2007; 14(1):59-63. PubMed ID: 17218231
[TBL] [Abstract][Full Text] [Related]
6. Current treatment of dysfunctional uterine bleeding.
Bongers MY; Mol BW; Brölmann HA
Maturitas; 2004 Mar; 47(3):159-74. PubMed ID: 15036486
[TBL] [Abstract][Full Text] [Related]
7. Office endometrial ablation with local anesthesia using the HydroThermAblator system: Comparison of outcomes in patients with submucous myomas with those with normal cavities in 246 cases performed over 5(1/2) years.
Glasser MH; Heinlein PK; Hung YY
J Minim Invasive Gynecol; 2009; 16(6):700-7. PubMed ID: 19896596
[TBL] [Abstract][Full Text] [Related]
8. Pathological findings associated with the presence of a mirena intrauterine system at hysterectomy.
Rizkalla HF; Higgins M; Kelehan P; O'Herlihy C
Int J Gynecol Pathol; 2008 Jan; 27(1):74-8. PubMed ID: 18156979
[TBL] [Abstract][Full Text] [Related]
9. Abnormal uterine bleeding and dysfunctional uterine bleeding in pediatric and adolescent gynecology.
Deligeoroglou E; Karountzos V; Creatsas G
Gynecol Endocrinol; 2013 Jan; 29(1):74-8. PubMed ID: 22946701
[TBL] [Abstract][Full Text] [Related]
10. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Wildemeersch D; Schacht E
Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
[TBL] [Abstract][Full Text] [Related]
11. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas.
Magalhães J; Aldrighi JM; de Lima GR
Contraception; 2007 Mar; 75(3):193-8. PubMed ID: 17303488
[TBL] [Abstract][Full Text] [Related]
12. Economic evaluation of the levonorgestrel-releasing intrauterine system for the treatment of dysfunctional uterine bleeding in Spain.
Lete I; Cristóbal I; Febrer L; Crespo C; Arbat A; Hernández FJ; Brosa M
Eur J Obstet Gynecol Reprod Biol; 2011 Jan; 154(1):71-80. PubMed ID: 20951492
[TBL] [Abstract][Full Text] [Related]
13. Modern management of abnormal uterine bleeding: the levonorgestrel intra-uterine system.
Mansour D
Best Pract Res Clin Obstet Gynaecol; 2007 Dec; 21(6):1007-21. PubMed ID: 17544330
[TBL] [Abstract][Full Text] [Related]
14. Levonorgestrel-IUD should be offered before hysterectomy for abnormal uterine bleeding without uterine structural abnormalities: there are no more excuses!
Dueholm M
Acta Obstet Gynecol Scand; 2009; 88(12):1302-4. PubMed ID: 19916888
[No Abstract] [Full Text] [Related]
15. Management of abnormal uterine bleeding in women with mechanical heart valve prosthesis and anticoagulant therapy.
Saha PK; Rakshit BM; Jana N; Dutta S; Roy SB; Sengupta G
J Indian Med Assoc; 2011 Dec; 109(12):908-11. PubMed ID: 23469574
[TBL] [Abstract][Full Text] [Related]
16. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
[TBL] [Abstract][Full Text] [Related]
17. The impact of alternative treatment for abnormal uterine bleeding on hysterectomy rates in a tertiary referral center.
van Dongen H; van de Merwe AG; de Kroon CD; Jansen FW
J Minim Invasive Gynecol; 2009; 16(1):47-51. PubMed ID: 18990612
[TBL] [Abstract][Full Text] [Related]
18. [Levonorgestrel-releasing intrauterine system in the treatment of dysfunctional uterine bleeding: A French multicenter study].
Yazbeck C; Omnes S; Vacher-Lavenu MC; Madelenat P
Gynecol Obstet Fertil; 2006 Oct; 34(10):906-13. PubMed ID: 16987684
[TBL] [Abstract][Full Text] [Related]
19. Re: The use of levonorgestrel-releasing intrauterine system for the treatment of menorrhagia in women with inherited bleeding disorders.
Curtis R; Inki P
BJOG; 2006 Feb; 113(2):248-9. PubMed ID: 16412011
[No Abstract] [Full Text] [Related]
20. The effect of levonorgestrel intrauterine system on uterine myomas: a 1-year follow-up study.
Gunes M; Ozdegirmenci O; Kayikcioglu F; Haberal A; Kaplan M
J Minim Invasive Gynecol; 2008; 15(6):735-8. PubMed ID: 18971138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
